Parental scaffolding in play: A comparison of fetal alcohol spectrum disorders and autism spectrum disorder.

Autism spectrum disorder Developmental disabilities Fetal alcohol spectrum disorders Parent-child play Parental scaffolding

Journal

Research in developmental disabilities
ISSN: 1873-3379
Titre abrégé: Res Dev Disabil
Pays: United States
ID NLM: 8709782

Informations de publication

Date de publication:
Aug 2023
Historique:
received: 26 07 2022
revised: 08 05 2023
accepted: 02 06 2023
pmc-release: 01 08 2024
medline: 31 7 2023
pubmed: 10 6 2023
entrez: 9 6 2023
Statut: ppublish

Résumé

Parental support of child play varies based on child needs; however, how parental play level differs from child play level remains an understudied area of research, especially in relation to specific developmental disabilities. To preliminarily explore differences in child and parent play levels in age- and IQ-matched children with fetal alcohol spectrum disorders (FASD) and autism spectrum disorder (ASD). and Procedures: Parent-child dyads were recorded during free-play sessions. Parent/child play levels were coded for highest level achieved during each minute of play. Mean play level and dPlay (difference in parent versus child play level) were calculated across play sessions for each dyad. On average, parents of children with FASD demonstrated higher levels of play than other parents. Children with FASD demonstrated higher levels of play than their own parents. In contrast, the play level of parents of children with ASD did not differ from their child's. There were no between-group differences in dPlay. This preliminary exploratory study suggests that parents of children with developmental disabilities may differentially 'match' their child's play level. Further research on developmental play levels during parent-child play is warranted.

Sections du résumé

BACKGROUND BACKGROUND
Parental support of child play varies based on child needs; however, how parental play level differs from child play level remains an understudied area of research, especially in relation to specific developmental disabilities.
AIMS OBJECTIVE
To preliminarily explore differences in child and parent play levels in age- and IQ-matched children with fetal alcohol spectrum disorders (FASD) and autism spectrum disorder (ASD).
METHODS METHODS
and Procedures: Parent-child dyads were recorded during free-play sessions. Parent/child play levels were coded for highest level achieved during each minute of play. Mean play level and dPlay (difference in parent versus child play level) were calculated across play sessions for each dyad.
OUTCOMES AND RESULTS RESULTS
On average, parents of children with FASD demonstrated higher levels of play than other parents. Children with FASD demonstrated higher levels of play than their own parents. In contrast, the play level of parents of children with ASD did not differ from their child's. There were no between-group differences in dPlay.
CONCLUSIONS AND IMPLICATIONS CONCLUSIONS
This preliminary exploratory study suggests that parents of children with developmental disabilities may differentially 'match' their child's play level. Further research on developmental play levels during parent-child play is warranted.

Identifiants

pubmed: 37295127
pii: S0891-4222(23)00131-2
doi: 10.1016/j.ridd.2023.104553
pmc: PMC10635817
mid: NIHMS1907396
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104553

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR000423
Pays : United States

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no conflict of interest.

Références

Eur J Paediatr Neurol. 2021 Jul;33:50-60
pubmed: 34058625
Child Care Health Dev. 2020 Mar;46(2):232-243
pubmed: 31867727
J Dev Behav Pediatr. 2014 Oct;35(8):475-85
pubmed: 25264862
Autism Res. 2019 Mar;12(3):469-481
pubmed: 30624017
J Child Psychol Psychiatry. 2006 Jun;47(6):611-20
pubmed: 16712638
J Child Psychol Psychiatry. 2007 Nov;48(11):1111-21
pubmed: 17995487
Semin Pediatr Neurol. 2011 Mar;18(1):49-55
pubmed: 21575841
Alcohol. 2016 Jun;53:9-18
pubmed: 27286932
Clin Epigenetics. 2018 Jan 12;10:5
pubmed: 29344313
BMJ Open. 2018 Mar 9;8(3):e013775
pubmed: 29525767
Am J Intellect Dev Disabil. 2013 Jan;118(1):3-15
pubmed: 23301899
Br J Educ Psychol. 2017 Jun;87(2):241-254
pubmed: 28220477
Children (Basel). 2023 Mar 13;10(3):
pubmed: 36980102
Rev J Autism Dev Disord. 2022;9(2):208-234
pubmed: 33821200
J Intellect Dev Disabil. 2013 Jun;38(2):95-104
pubmed: 23672658
Alcohol Clin Exp Res. 2001 Jul;25(7):1018-24
pubmed: 11505027
BMC Pediatr. 2019 Dec 16;19(1):498
pubmed: 31842817
Biochem Cell Biol. 2018 Apr;96(2):241-251
pubmed: 28521112
Autism Res. 2022 Aug;15(8):1565-1575
pubmed: 35437928
BMC Pediatr. 2018 Feb 9;18(1):46
pubmed: 29426320
Front Pediatr. 2020 Dec 02;8:581893
pubmed: 33344381
Matern Child Health J. 2014 Aug;18(6):1496-505
pubmed: 24178158
Occup Ther Int. 2018 Oct 01;2018:4636780
pubmed: 30364095
J Popul Ther Clin Pharmacol. 2013;20(3):e416-67
pubmed: 24323701
Autism. 2013 Mar;17(2):147-61
pubmed: 23382513
Res Dev Disabil. 2019 Nov;94:103494
pubmed: 31520962
Top Lang Disord. 2007 Jul 1;27(3):226-241
pubmed: 20072702
J Pediatr Health Care. 2017 Sep - Oct;31(5):594-606
pubmed: 28838601
Alcohol Clin Exp Res. 2006 Dec;30(12):2037-45
pubmed: 17117969
Pediatrics. 2018 Sep;142(3):
pubmed: 30126932
Autism. 2011 Jan;15(1):43-64
pubmed: 20923889
Alcohol Clin Exp Res. 2012 Apr;36(4):568-76
pubmed: 22017360
Int J Environ Res Public Health. 2019 Dec 11;16(24):
pubmed: 31835865
Child Dev. 2018 May;89(3):e157-e166
pubmed: 28548711
J Child Psychol Psychiatry. 2007 Mar-Apr;48(3-4):329-54
pubmed: 17355401
J Autism Dev Disord. 2022 Sep 27;:
pubmed: 36167887
Children (Basel). 2021 May 17;8(5):
pubmed: 34067856
Am J Ment Retard. 2008 Jan;113(1):1-18
pubmed: 18173297
J Child Neurol. 2012 Mar;27(3):355-62
pubmed: 22241713
Alcohol Clin Exp Res. 2021 Dec;45(12):2448-2464
pubmed: 34716704
Autism Res. 2008 Dec;1(6):354-63
pubmed: 19360690
J Child Psychol Psychiatry. 2013 Feb;54(2):216-24
pubmed: 22823182
Health Soc Work. 1981 Feb;6(1):5-10
pubmed: 7215990
Hum Brain Mapp. 2018 May;39(5):2258-2268
pubmed: 29436054
J Learn Disabil. 1998 Jul-Aug;31(4):344-64
pubmed: 9666611
J Popul Ther Clin Pharmacol. 2014;21(1):e81-e105
pubmed: 24615395
Am J Intellect Dev Disabil. 2022 Sep 1;127(5):355-368
pubmed: 36018765
Alcohol Clin Exp Res. 2020 Apr;44(4):815-819
pubmed: 32128856
BMC Pediatr. 2020 Jun 3;20(1):275
pubmed: 32493264
Health Technol Assess. 2018 Jan;22(3):1-150
pubmed: 29345224
Acta Neuropsychiatr. 2019 Apr;31(2):74-83
pubmed: 30449293
Dev Psychopathol. 2020 Oct;32(4):1230-1239
pubmed: 32893764
Afr J Disabil. 2019 Oct 21;8:592
pubmed: 31745462
Front Psychol. 2020 Aug 28;11:1978
pubmed: 32982835
J Clin Child Adolesc Psychol. 2002 Mar;31(1):130-46
pubmed: 11845645
Child Neuropsychol. 2021 Jan;27(1):125-149
pubmed: 32819180
Aust Occup Ther J. 2014 Aug;61(4):259-67
pubmed: 24547920
Child Care Health Dev. 2021 Sep;47(5):675-684
pubmed: 33942905
Appl Neuropsychol Child. 2017 Apr-Jun;6(2):120-137
pubmed: 27049769
Can Child Adolesc Psychiatr Rev. 2003 Aug;12(3):72-6
pubmed: 19030528
Br J Dev Psychol. 2013 Mar;31(Pt 1):114-27
pubmed: 23331110
Front Psychol. 2021 Apr 26;12:646074
pubmed: 33981273
J Autism Dev Disord. 2021 May;51(5):1658-1667
pubmed: 32808150
J Child Psychol Psychiatry. 2011 May;52(5):571-9
pubmed: 20860756
Front Psychol. 2016 Oct 13;7:1577
pubmed: 27790175
PLoS One. 2022 Sep 9;17(9):e0274238
pubmed: 36084103

Auteurs

Julia T Mattson (JT)

Department of Pediatrics, University of Washington, Seattle, WA, United States of America. Electronic address: juliatm@uw.edu.

John C Thorne (JC)

Department of Speech & Hearing Sciences, University of Washington, Seattle, WA, United States of America.

Sara T Kover (ST)

Department of Speech & Hearing Sciences, University of Washington, Seattle, WA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH